BioClin Therapeutics competitorsClear all

BioClin Therapeutics's top competitors include Karyopharm Therapeutics, Calithera Biosciences, Clovis Oncology and Merrimack Pharmaceuticals.
BioClin Therapeutics
BioClin Therapeutics
BioClin Therapeutics is a privately-held biotechnology developing biologics to address medical conditions where there is significant unmet need.
Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Calithera Biosciences
Calithera Biosciences
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Clovis Oncology
Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Founding Date
Founding Date
2010
Founding Date
2008
Founding Date
2010
Founding Date
2009
Founding Date
2000
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Ramon, US HQ
Locations
Newton, US HQ
München, DE
Tel Aviv Yafo, IL
Locations
South San Francisco, US HQ
Locations
Boulder, US HQ
Locations
Cambridge, US HQ
Employees
Employees
25
Employees
N/A
Employees
798% increase
Employees
46830% increase
Employees
2763% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
207.2 m
Valuation ($)
730.9 m
Valuation ($)
76.9 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
663
Twitter followers
1.1 k
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
271704
Alexa Website Rank
202588
Alexa Website Rank
217363
Alexa Website Rank
400267

Financial

Net income
Net income
N/A
Net income
($178.4m) (FY, 2018)
Net income
($54.6m) (FY, 2018)
Net income
($368m) (FY, 2018)
Net income
($40.5m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 69m
Total funding raised
$ 248.7m
Total funding raised
$ 182m
Total funding raised
$ 357m
Total funding raised
$ 79.4m
For sources of this data, please see the company profile

View company profiles

Karyopharm Therapeutics
HQ
Newton, US

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

View company
Calithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase

Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

View company
Clovis Oncology
HQ
Boulder, US
Employees
468↑ 30% increase

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company